Multicenter ML Study Opens: Predicting ABPA Exacerbation Risk to Transform Clinical Decision-Making in Allergic Bronchopulmonary Aspergillosis

References

1. 1.Qianfoshan Hospital. (2025). Machine learning-based prediction of recurrence risk in allergic bronchopulmonary aspergillosis and its clinical decision-making value: A multicenter study with external validation (NCT07714863). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07714863
2. 2.Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., & Denning, D. W. (2013). Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clinical & Experimental Allergy, 43(8), 850–873. https://doi.org/10.1111/cea.12141
3. 3.Agarwal, R., Muthu, V., Sehgal, I. S., Dhooria, S., Prasad, K. T., & Aggarwal, A. N. (2024). Allergic bronchopulmonary aspergillosis: Updates in the ISHAM-ABPA Working Group guidelines. Medical Mycology, 62(5), myae039. https://doi.org/10.1093/mmy/myae039
4. 4.Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022). AI in health and medicine. Nature Medicine, 28(1), 31–38. https://doi.org/10.1038/s41591-021-01614-0
5. 5.Lundberg, S. M., & Lee, S. I. (2017). A unified approach to interpreting model predictions. Advances in Neural Information Processing Systems, 30, 4765–4774. https://doi.org/10.48550/arXiv.1705.07874
6. 6.Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., Segal, B. H., Steinbach, W. J., Stevens, D. A., Walsh, T. J., Wingard, J. R., Young, J. A., & Bennett, J. E. (2016). Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 63(4), e1–e60. https://doi.org/10.1093/cid/ciw326